We study muscular dystrophies and cardiomyoapathies using patient-derived induced pluripotent cells (iPS)
We are deciphering dynamic regulatory networks controlling nuclear reprogramming
We are developing molecular approaches to rejuvenate cells to combat aging
We are developing ways to extend telomeres transiently and safely to augment cell proliferative capacity and treat disease
We use interdisciplinary approaches — biomaterials, imaging, single cell proteomics, genomics and tracking
We use single cell proteomic and genomic technologies to identify novel therapeutic targets to rejuvenate muscle stem cell function and regeneration
Copyright (c) 2015-2016.